Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.72 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.43 |
| ▸ | APP | P05067 | 5/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| E637 SCHEMBL11019418 | 0.98 | LMNA (0.70) | LMNAKDM4EALOX5APPGAA | |
| E637 SCHEMBL1870685 | 0.91 | KDM4E (0.55) | LMNAKDM4EALOX5APPMAPK1 | |
| E637 SCHEMBL41817 | 0.91 | KDM4E (0.55) | LMNAKDM4EALOX5APPMAPK1 | |
| E637 SCHEMBL6657728 | 0.89 | KDM4E (0.53) | LMNAKDM4EALOX5APPMAPK1 | |
| E637 SCHEMBL27635951 | 0.89 | KDM4E (0.53) | LMNAKDM4EALOX5APPMAPK1 | |
| E637 SCHEMBL23309786 | 0.89 | KDM4E (0.53) | LMNAKDM4EALOX5APPMAPK1 | |
| E637 SCHEMBL8026696 | 0.89 | KDM4E (0.53) | LMNAKDM4EALOX5APPMAPK1 | |
| Maltol SCHEMBL4815 | 0.85 | — | — | |
| Maltol SCHEMBL901231 | 0.85 | KDM4E (1.00) | LMNAKDM4EALOX5APPGAA | |
| E637 SCHEMBL14990891 | 0.84 | KDM4E (0.48) | LMNAKDM4EALOX5APPGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10260022-B2 | Microcapsules imparting intense vanilla odor note | FIRMENICH SA (CH) | 2019-04-16 | — | — | US | disclosed |
| EP-3253455-B1 | MICROCAPSULES IMPARTING INTENSE VANILLA ODOR NOTE | FIRMENICH & CIE (CH) | 2019-04-10 | — | — | EP | disclosed |
| US-20180023033-A1 | MICROCAPSULES IMPARTING INTENSE VANILLA ODOR NOTE | FIRMENICH SA (CH) | 2018-01-25 | — | — | US | disclosed |
| WO-2016124746-A1 | MICROCAPSULES IMPARTING INTENSE VANILLA ODOR NOTE | FIRMENICH SA (CH) | 2016-08-11 | — | — | WO | disclosed |
| US-20120082631-A1 | COMPOSITIONS | GIVAUDAN SA (CH) | 2012-04-05 | — | — | US | disclosed |
| EP-2427248-A2 | ZINC COMPRISING ORAL CARE COMPOSITIONS HAVING REDUCED ASTRINGENCY | Givaudan SA (CH) | 2012-03-14 | — | — | EP | disclosed |
| WO-2010128164-A2 | COMPOSITIONS | GIVAUDAN SA (CH) | 2010-11-11 | — | — | WO | disclosed |
| CN-1048981-A | Chrysanthemum products removes living green grass or young crops, pained abnormal smells from the patient method and prescription | HUANG GUOGANG (CN) | 1991-02-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10260022-B2 | Microcapsules imparting intense vanilla odor note | TRPC5, TRPV5, TRPM5 | LMNA 4467/4885KDM4E 1690/4885ALOX5 44/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.